TAM Center’s Future: Innovative Combination Targeted Treatments
TAM Center hospital has been at the forefront of immunotherapy for the past 42 years. Since the institution’s inception and due to our longevity as a cancer hospital, we are now able to relish in the now-approved treatments and/or variations of treatments being approved by the Food and Drug Administration (FDA) of the United States.
There is no doubt that the approval of checkpoint inhibitor therapy was a giant leap forward in the field of Oncology. In return, patients around the world are living longer than ever before with various solid tumor cancers.
It should be noted that TAM Center scientists and doctors were committed to immunotherapy for cancer well before it was popular or accepted as a mainstream treatment. In the 1980’s TAM Center used mistletoe combined with Gerson Therapy. In the 1990’s Dr. Josef Issels joined the TAM Center staff from Germany. He brought his experience with Coley’s toxins and peptides.
In 1999 TAM Center made its first dendritic cell and tumor-lysed vaccine. And in 2008 we used our first checkpoint inhibitor.
For 42 years TAM Center has advocated for immunotherapy treatments for patients. Our undeniable anecdotal results of individual human lives allowed us to stand tall in the face of naysayers and scrutiny. While mainstream science dismisses individual results, the families of loved ones and patients that live longer surely appreciate it.
We, at TAM Center, are creating an opportunity to expedite lifesaving therapeutic options and make them readily available to all patients. Never before has TAM Center been in a position to gather more than just basic patient information, rather we are obtaining more specialized and detailed specifics about a patient’s individual cancer or cancer type. The combination of this feature coupled with translational clinical labs helps to create a targeted treatment plan (in-house); that can increase the current rate of saving lives.
TAM Center is at the precipice of a revolutionary evolution. Over the next 12 months, we will be embarking on an extensive remodeling schedule for the entire hospital. A transformation from its current identity, into a new state-of-the-art cancer center of excellence.
AI Organized Medical Records
Our AI platform transforms complex unstructured medical data directly from your medical records even if from multiple hospitals, into structured and organized format. This makes the medical records easier to read and review while making the data suitable for analysis and machine learning.
Assisted by AI the platform then aggregates, organizes, and structures medical records into datasets that gives you and your medical team access to the most promising treatment options.
Processing Your Data
Next Generation Sequencing + Optical Genome Mapping + Proteomics = Information on patient’s individual cancer. (CREATE GRAPHIC)